title: [Quality of life of malignant patients after autologous stem cell transplantation].
abstract: OBJECTIVE
  To investigate the quality of life of Chinese malignant patients who treated with the high dose chemoradiotherapy combined with autologous stem cell transplantation (ASCT).
  
  
  METHODS
  The data of 89 patients who answer the EORTC QLQ-C30 Chinese version 3.0 after finished ASCT and disease free were analyzed using SPSS 10.0.
  
  
  RESULTS
  The score of global health status and functional assessment were near or over 80, more than 80 percent of patient had good or very good global health status or function, the patients who were experiencing moderate or severe financial dysfunction, fatigue, dyspnea, sleeping disturbance and diarrhea were in 72.5% (65/89), 50.6% (45/89), 42.7% (38/89), 33.7% (30/89) and 32.5% (29/89) respectively. The score of dyspnea in female patients was significant higher than male patients (P = 0.024). The score of global health status (P = 0.000), physical function (P = 0.000), role function (P = 0.031) and social function (P = 0.029) became higher significantly with time from transplantation and the score of fatigue became lower (P = 0.020). The Hodgkin's lymphoma patients had higher score significantly in nausea & vomiting (P = 0.002) and dyspnea (P = 0.006) than NHL. The age at transplantation and evaluation took none effect on the score.
  
  
  CONCLUSIONS
  Most patient have good global health status and function after autologous stem cell transplantation, they are more suffered from financial dysfunction, fatigue, dyspnea, sleeping disturbance and diarrhea. Females have more dyspnea symptoms, the quality of life of patient will improve gradually with the time from transplantation, the Hodgkin's lymphoma patients have more symptoms than non-Hodgkin's lymphoma patients, we do not find any effect of age at transplantation and assessment on the quality of life.
authors.affiliation: Department of Medical Oncology, Cancer Hospital & Institute of CAMS & PUMC, Beijing 100021, China.
authors.forename: Bin
authors.initials: B
authors.lastname: Ai
authors.forename: Yuan-kai
authors.initials: YK
authors.lastname: Shi
authors.forename: Xiao-hui
authors.initials: XH
authors.lastname: He
authors.forename: Xiao-hong
authors.initials: XH
authors.lastname: Han
authors.forename: Li-ya
authors.initials: LY
authors.lastname: Zhao
authors.forename: Sheng-yu
authors.initials: SY
authors.lastname: Zhou
authors.forename: Peng
authors.initials: P
authors.lastname: Liu
authors.forename: Jian-liang
authors.initials: JL
authors.lastname: Yang
authors.forename: Chang-gong
authors.initials: CG
authors.lastname: Zhang
authors.forename: Ding-zhi
authors.initials: DZ
authors.lastname: Huang
authors.forename: Yan
authors.initials: Y
authors.lastname: Qin
authors.forename: Sheng
authors.initials: S
authors.lastname: Yang
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D011788:Quality of Life; D011795:Surveys and Questionnaires; D014182:Transplantation, Autologous; D055815:Young Adult